English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18074/20272 (89%)
造訪人次 : 4072976      線上人數 : 791
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/29608


    標題: Does Renal Dysfunction Modify the Effect of Intravenous Thrombolysis for Acute Ischemic Stroke within 4.5 Hours of Onset? A Multicenter Observational Study
    作者: Hsieh, Cheng-Yang
    Lin, Huey-Juan
    Sung, Sheng-Feng
    Yang, Yea-Huei Kao
    Lai, Edward Chia-Cheng
    Hsieh, Han-Chieh
    Chen, Chih-Hung
    貢獻者: 化粧品應用與管理系
    關鍵字: Renal dysfunction
    Thromboly tictherapy
    Tissue plasminogen activator
    Cerebral hemorrhage
    Glomerular filtration rate
    risk
    日期: 2015-03
    上傳時間: 2016-04-19 19:01:53 (UTC+8)
    出版者: Elsevier Science Bv
    摘要: Background: About one third of stroke patients have renal dysfunction. Effect of renal dysfunction on outcome of intravenous thrombolysis (IVT) for acute ischemic stroke (AIS) has not been determined in Asia using patients without IVT as comparators. The aim of this study was to examine the interaction between renal dysfunction and IVT on the outcomes in AIS patients admitted within 4.5 hours of onset in a multicenter stroke registry of Taiwan. Methods: We identified all consecutive AIS patients admitted within 4.5 hours of onset between 2007 and 2013. Renal dysfunction was defined by an estimated glomerular filtration rate less than 60 mL/minute/ 1.73 m(2) on initial admission. Patients older than 80 years of age and a National Institute of Health Stroke Scale score less than 4 or greater than 25 were excluded. The primary outcome was a modified Rankin Scale score 3-6 at 3 months. We determined the effect of IVT and renal dysfunction on outcome in a multivariate analysis. Results: Of the 929 patients analyzed, 39% had renal dysfunction, and 51% received IVT. Primary outcomes occurred in 45% versus 41% of patients with and without renal dysfunction, respectively, (P = .197). In a multivariate analysis, the odds ratios (95% confidence interval; P value) of IVT and renal dysfunction for primary outcome were .70 (. 51-. 96; P = .029) and .97 (. 71-1.33; P = .865), respectively. No significant interaction was noted between IVT and renal dysfunction (P = .218). Conclusions: Renal dysfunction did not modify the effect of IVT for AIS and should not be a reason for withholding treatment from otherwise-eligible patients.
    關聯: Journal of Stroke & Cerebrovascular Diseases, v.24 n.3, pp.673-679
    顯示於類別:[化妝品應用與管理系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML1547檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋